Argenx
ARGX
#573
Rank
A$54.23 B
Marketcap
$907.06
Share price
0.06%
Change (1 day)
21.68%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : A$7.34 Billion

According to Argenx 's latest financial reports the company's total assets are A$7.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2022-12-31A$4.60 B17.15%
2021-12-31A$3.93 B7.83%
2020-12-31A$3.64 B41.52%
2019-12-31A$2.57 B139.76%
2018-12-31A$1.07 B57.12%
2017-12-31A$0.68 B321.3%
2016-12-31A$0.16 B115.23%
2015-12-31A$75.42 M-28.67%
2014-12-31A$0.10 B97.72%
2013-12-31A$53.47 M83.22%
2012-12-31A$29.18 M-27.85%
2011-12-31A$40.45 M151.96%
2010-12-31A$16.05 M